The Food and Drug Administration inspected Legacy Donor Services Foundation in Jacksonville on April 21, evaluating the facility for compliance related to human cellular, tissue, and gene therapies, according to data published by the FDA.
The inspection report determined Legacy Donor Services Foundation did not require any corrective actions for its managing operations.
The FDA regularly inspects facilities throughout the U.S. to verify workplace and product compliance with laws and regulations aimed at promoting public health. The agency later makes inspection outcomes available to the public.
Its website notes the FDA is a federal agency chiefly tasked with overseeing the safety and quality of human and animal drugs, biological products, medical devices and tobacco products.
Information for this article comes from the U.S. Food and Drug Administration. The source material can be accessed here.
